Procter & Gamble stock holds near record as cost risks persist

Published on 11/05/2026 at 14:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Procter & Gamble stock faces a sharper margin test as commodity costs rise. Fiscal 2027 guidance remains intact after a volume-led first quarter.

Growth Meets A Heavier Cost Load

Fiscal first-quarter net sales and organic sales both increased 4 percent year over year.
Volume contributed 2.4 percentage points, while pricing added 0.4 points and product mix 1.1 points.
Management kept its fiscal 2027 organic-sales and core-EPS outlook despite higher commodity, energy and transportation costs.

Procter & Gamble, US7427181091, Illustration mit AI erstellt.

Procter & Gamble reported a stronger start to fiscal 2027 on October 22, with first-quarter sales and organic growth both advancing 4 percent from a year earlier. The company maintained its full-year outlook, but its forecast for higher raw-material, energy and transportation costs keeps margin execution central for investors.

According to TokenPost, net sales reached USD 23.276 billion in the three months ended September 30. Core earnings per share came to USD 2.00, above the higher of two cited estimates of USD 1.89, while reported diluted earnings per share were USD 1.97, up 1 percent year over year. Core EPS is a non-GAAP measure that excludes certain items, including incremental restructuring costs.

Volume Supports The First Quarter

Volume was the largest contributor to organic sales growth, adding 2.4 percentage points. Pricing contributed 0.4 points and product mix added 1.1 points. The comparison remains favorable but demanding: the year-earlier first quarter delivered 3 percent net sales growth and 2 percent organic growth.

The breadth of the result supports Procter & Gamble's effort to restore volume-led growth after a period in which pricing carried more of the burden. For the stock, the key question is whether volumes can continue to offset cost inflation without requiring heavier price increases that could pressure consumer demand.

Guidance Meets Cost Pressure

Management retained its fiscal 2027 forecast for organic sales growth of 1 percent to 3 percent and core EPS of USD 6.89 to USD 7.11. The company also expects all-in sales growth of 2 percent to 4 percent, including the Thorne acquisition effective October 1. The organic-sales range excludes acquisitions and divestitures, while the all-in outlook includes the transaction.

Procter & Gamble expects commodity costs to reduce fiscal 2027 results by USD 1.4 billion after tax. Chief Executive Officer Shailesh Jejurikar said the strong opening quarter kept the company on track to deliver within its organic-sales, core-EPS and free-cash-flow productivity ranges. That guidance places greater importance on productivity gains and execution as the year progresses.

Stock Holds Above Prior Xetra Close

Procter & Gamble stock traded at EUR 150.32 on Lang & Schwarz at 14:43 CET on Thursday, November 5, 2026, 0.47 percent above the Xetra close of Wednesday, November 4. Investors can follow the real-time quote of Procter & Gamble stock.

For investors, the next major test is the January fiscal-second-quarter report, when the company will have to show whether volume gains and productivity can absorb the expected cost burden while keeping its annual ranges credible.